FIELD: medicine; pharmaceuticals.
SUBSTANCE: disclosed is synthetic hepatoprotective agent of pyrimidine row. Offered application of L-ascorbate of 1-(2-hydroxyethyl)-4,6-dimethyl-1,2-dihydropyrimidin-2-one derivatives of formula I.
EFFECT: compound possesses the ability to reduce functional and structural disorders of hepatocytes and providing faster recovery of structure and function of liver at toxic hepatitis; clinical effectiveness in terms of AlAT and AcAT higher than that of xymedone.
1 cl, 2 tbl
formula I
Title | Year | Author | Number |
---|---|---|---|
HEPATOPROTECTIVE AGENT FROM ALGAE | 2013 |
|
RU2528898C1 |
HEPATOPROTECTIVE AGENT FROM ALGAE | 2017 |
|
RU2667472C1 |
PHYSICAL PERFORMANCE STIMULATING AGENT | 2013 |
|
RU2515247C1 |
HEPATOPROTECTIVE AGENT FOR PROPHYLAXIS OF TETRACYCLINE LIVER DAMAGE | 0 |
|
SU1822772A1 |
AN AQUEOUS SOLUTION SHOWING HEPATOPROTECTIVE EFFECT | 1996 |
|
RU2111746C1 |
HEPATOPROTECTIVE SUBSTANCE | 2015 |
|
RU2614691C2 |
AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
HEPATOPROTECTOR | 2010 |
|
RU2444569C1 |
PHARMACEUTICAL COMPOSITION ELICITING HEPATOPROTECTIVE EFFECT AND MEDICINAL AGENT | 2003 |
|
RU2257208C1 |
HEPATOPROTECTIVE, CARDIOPROTECTIVE AND PLACENTAPROTECTIVE, UTEROLITH AND NO-MIMETIC COMBINED DRUG | 2015 |
|
RU2597785C1 |
Authors
Dates
2016-07-10—Published
2015-05-26—Filed